Partnership announced with Metamorph AI
NEW
YORK, May 21, 2024 /PRNewswire-PRWeb/ --
Fluence, a global leader in evidence-based psychedelic therapy
training, has announced a partnership with Metamorph AI, a
pioneering AI technology company, to develop an AI-powered tool to
enhance the training of psychedelic therapists.
We believe this partnership will set a new
standard for psychedelic therapy training and pave the way for more
humanizing applications of AI in the healthcare industry.
Together, Fluence and Metamorph AI have created an automated
generative AI tool that analyzes transcripts of therapist role-play
sessions and provides comprehensive feedback based on pre-existing
adherence criteria. By leveraging Metamorph AI's expertise in Large
Language Models (LLMs) and Fluence's extensive experience in
creating and delivering psychedelic therapy training, the
partnership seeks to empower human therapists with AI-assisted
feedback, ultimately enhancing the quality of psychedelic therapy
and integration services.
"Our partnership with Metamorph AI represents a significant step
forward in the field of psychedelic therapy training," said
Ingmar Gorman, Ph.D., Fluence
co-founder and CEO. "By harnessing the power of generative AI, we
can provide our trainees with timely, thorough, and actionable
feedback, enabling them to refine their skills and deliver more
effective therapy."
The AI tool analyzes therapist role-play sessions, identifying
areas for improvement and providing constructive feedback. For
instance, if a therapist changes the subject after a patient brings
up something emotionally complex, the tool will highlight the
missed therapeutic opportunity to delve deeper in the AI-generated
report. Fluence's experienced instructors then use the feedback to
save time reviewing individual role-play sessions. Trainees in some
programs will also receive written output directly from the AI
tool, allowing them to focus on specific areas of improvement.
"The rapid advancements in AI have opened up endless
possibilities for enhancing human capabilities," said Aurora Quinn-Elmore, CEO of Metamorph AI. "Our
collaboration with Fluence showcases how AI can be used to empower
and support human therapists. We believe this partnership will set
a new standard for psychedelic therapy training and pave the way
for more humanizing applications of AI in the healthcare
industry."
Fluence is implementing this cutting-edge technology as part of
its training program for therapists participating in multiple
psychedelic clinical trials conducted by partners including Reunion
Neuroscience and Cybin, further demonstrating the real-world
applications of this innovative AI-assisted approach.
"Innovations in facilitator learning and development are crucial
for scalability of psychedelic treatments post-approval," said
Alex Kelman, Ph.D., Head of
Therapies at Cybin. "Fluence is demonstrating excellent leadership
in exploring and integrating technology-based competency
development and assessment tools."
Greg Mayes, CEO of Reunion
Neuroscience, said: "At Reunion Neuroscience, we are committed to
advancing innovative treatments for mental health conditions. Our
partnership with Fluence, and their groundbreaking collaboration
with Metamorph AI, exemplifies our dedication to leveraging
cutting-edge technologies to enhance the quality and scalability of
psychedelic therapy. We believe this AI-powered training tool will
not only benefit our clinical trials but also contribute to the
broader field of psychedelic-assisted therapy, ultimately improving
patient outcomes."
With over 7,000 practitioners educated since its inception,
Fluence has established itself as a frontrunner in psychedelic
therapy training for private enterprises and research
organizations. By partnering with Metamorph AI, Fluence is poised
to revolutionize the field of psychedelic therapy training and
unlock new possibilities for therapist development.
About Fluence
Fluence is the global leader in providing comprehensive,
evidence-based training in psychedelic therapy and integration to
healthcare professionals. With a mission to equip clinicians with
the clinical skills and knowledge necessary for effective,
evidence-based psychedelic therapy and integration services,
Fluence offers ethical, dynamic, interactive training both online
and in-person. Since its inception, Fluence has educated over 7,000
practitioners, establishing itself as a frontrunner in psychedelic
therapy training for private enterprises and research
organizations.
About Metamorph AI
Metamorph AI is a team of business-focused engineers and AI
experts with practical experience applying AI to real business
problems. The team is dedicated to helping clients stay up-to-date
with advances in AI so that they can recognize and act on
opportunities as they emerge to leverage new capabilities that will
increasingly reshape industries.
Media Contact
Brad Burge, Fluence, 1
6508636887, brad@integrationcommunications.com,
https://www.fluencetraining.com
View original content to download
multimedia:https://www.prweb.com/releases/fluence-launches-generative-ai-tools-for-psychedelic-therapist-training-302152128.html
SOURCE Fluence